198 related articles for article (PubMed ID: 2551925)
1. Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.
Liang CS; Fan TH; Sullebarger JT; Sakamoto S
J Clin Invest; 1989 Oct; 84(4):1267-75. PubMed ID: 2551925
[TBL] [Abstract][Full Text] [Related]
2. Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Liang CS; Himura Y; Kashiki M; Stevens SY
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1863-72. PubMed ID: 12384464
[TBL] [Abstract][Full Text] [Related]
3. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.
Himura Y; Felten SY; Kashiki M; Lewandowski TJ; Delehanty JM; Liang CS
Circulation; 1993 Sep; 88(3):1299-309. PubMed ID: 8102598
[TBL] [Abstract][Full Text] [Related]
4. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
Fan TH; Liang CS; Kawashima S; Banerjee SP
Eur J Pharmacol; 1987 Aug; 140(2):123-32. PubMed ID: 2822436
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure.
Kawai H; Fan TH; Dong E; Siddiqui RA; Yatani A; Stevens SY; Liang CS
Am J Physiol; 1999 Oct; 277(4):H1609-17. PubMed ID: 10516201
[TBL] [Abstract][Full Text] [Related]
6. Transmural heterogeneity of norepinephrine uptake in failing human hearts.
Beau SL; Saffitz JE
J Am Coll Cardiol; 1994 Mar; 23(3):579-85. PubMed ID: 8113537
[TBL] [Abstract][Full Text] [Related]
7. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
Liang CS; Frantz RP; Suematsu M; Sakamoto S; Sullebarger JT; Fan TM; Guthinger L
Circulation; 1991 Jul; 84(1):254-66. PubMed ID: 1676348
[TBL] [Abstract][Full Text] [Related]
8. Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies.
Mardon K; Montagne O; Elbaz N; Malek Z; Syrota A; Dubois-Randé JL; Meignan M; Merlet P
J Nucl Med; 2003 Sep; 44(9):1459-66. PubMed ID: 12960192
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content.
Delehanty JM; Himura Y; Elam H; Hood WB; Liang CS
Am J Physiol; 1994 Mar; 266(3 Pt 2):H930-5. PubMed ID: 8160840
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure.
Kawai H; Mohan A; Hagen J; Dong E; Armstrong J; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1708-16. PubMed ID: 10775152
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats.
Backs J; Bresch E; Lutz M; Kristen AV; Haass M
Cardiovasc Res; 2005 Aug; 67(2):283-90. PubMed ID: 16005303
[TBL] [Abstract][Full Text] [Related]
12. Chronic opiate-receptor inhibition in experimental congestive heart failure in dogs.
Yatani A; Imai N; Himura Y; Suematsu M; Liang CS
Am J Physiol; 1997 Jan; 272(1 Pt 2):H478-84. PubMed ID: 9038970
[TBL] [Abstract][Full Text] [Related]
13. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins.
Liang C; Rounds NK; Dong E; Stevens SY; Shite J; Qin F
Circulation; 2000 Jul; 102(1):96-103. PubMed ID: 10880421
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-day hypoxia on cardiac adrenergic neurotransmission in rats.
Mardon K; Merlet P; Syrota A; Mazière B
J Appl Physiol (1985); 1998 Sep; 85(3):890-7. PubMed ID: 9729562
[TBL] [Abstract][Full Text] [Related]
15. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation.
Backs J; Haunstetter A; Gerber SH; Metz J; Borst MM; Strasser RH; Kübler W; Haass M
J Mol Cell Cardiol; 2001 Mar; 33(3):461-72. PubMed ID: 11181015
[TBL] [Abstract][Full Text] [Related]
16. Myocardial sympathetic denervation prevents chamber-specific alteration of beta-adrenergic transmembrane signaling in rabbits with heart failure.
Anzai T; Yoshikawa T; Baba A; Nishimura H; Shiraki H; Nagami K; Suzuki M; Wainai Y; Ogawa S
J Am Coll Cardiol; 1996 Nov; 28(5):1314-22. PubMed ID: 8890832
[TBL] [Abstract][Full Text] [Related]
17. Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol.
Fan TH; Frantz RP; Elam H; Sakamoto S; Imai N; Liang CS
Am J Physiol; 1993 Dec; 265(6 Pt 2):H2086-93. PubMed ID: 8285248
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart.
Yoshikawa T; Handa S; Suzuki M; Nagami K
J Am Coll Cardiol; 1994 Jul; 24(1):210-5. PubMed ID: 8006268
[TBL] [Abstract][Full Text] [Related]
19. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
Merlet P; Dubois-Randé JL; Adnot S; Bourguignon MH; Benvenuti C; Loisance D; Valette H; Castaigne A; Syrota A
J Cardiovasc Pharmacol; 1992 Jan; 19(1):10-6. PubMed ID: 1375674
[TBL] [Abstract][Full Text] [Related]
20. Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Somsen GA; Dubois EA; Brandsma K; de Jong J; van der Wouw PA; Batink HD; van Royen EA; Lie KI; van Zwieten PA
Cardiovasc Res; 1996 Jan; 31(1):132-8. PubMed ID: 8849597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
